Form4insider filings, from the source

SEC Form 3 · accession 0000899243-18-027664

Esperion Therapeutics, Inc. · ESPR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Joseph Lewis
10% Owner
Braslyn Ltd.
10% Owner
Period of report
Oct 26, 2018
Accepted (ET)
Oct 30, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———1,401,000D
Common StockF2holding———1,201,250D
Common StockF3holding———100D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Call OptionF2$50.00holding———Oct 25, 2018Mar 15, 2019Common Stock100,000—D
Call OptionF2$60.00holding———Oct 25, 2018Mar 15, 2019Common Stock70,000—D

Explanation of responses